(Q68096235)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3261129%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

title

A single infusion of the bisphosphonate AHPrBP (APD) as treatment of Paget's disease of bone (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3261129%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

main subject

Paget's disease of bone

1 reference

D Thiébaud

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3261129%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

P Jaeger

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3261129%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

C Gobelet

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3261129%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

A F Jacquet

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3261129%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

P Burckhardt

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3261129%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

publication date

1 August 1988

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3261129%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Medicine

21 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3261129%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

volume

85

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3261129%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3261129%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

page(s)

207-212

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3261129%20AND%20SRC:MED&resulttype=core&format=json

Rheumatic manifestations of Paget's disease of bone

21 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980344-9

Musculoskeletal manifestations of Paget's disease of bone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980344-9

Orthopedic aspects of Paget's disease of bone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980344-9

Paget's disease of bone. An update on management.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980344-9

Diphosphonate Therapy of Paget's Disease of Bone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980344-9

Sodium etidronate in the treatment of Paget's disease of bone. A study of long-term results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980344-9

Effects of disodium dichloromethylene diphosphonate on Paget's disease of bone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980344-9

Treatment of Paget's disease with (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate (A.P.D.)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980344-9

Use of etidronate (EHDP) in Paget's disease of bone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980344-9

The influence of two diphosphonates on calcium metabolism in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980344-9

Structure-activity relationships of various bisphosphonates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980344-9

Kinetic studies of bone and mineral metabolism during treatment with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD) in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980344-9

Quantitative morphometric evaluation of the inhibitory activity of new aminobisphosphonates on bone resorption in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980344-9

Biochemical and clinical responses to dichloromethylene diphosphonate (Cl2MDP) in Paget's disease of bone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980344-9

Differential action of the bisphosphonates (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD) and disodium dichloromethylidene bisphosphonate (Cl2MDP) on rat macrophage-mediated bone resorption in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980344-9

Clinical and biological effects of low doses of (3 amino-1 hydroxypropylidene)-1,1-bisphosphonate (APD) in Paget's disease of bone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980344-9

APD in Paget's disease of bone. Role of the mononuclear phagocyte system?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980344-9

Low dose intravenous 3-amino-1-hydroxypropylidene-1,1-bisphosphonate (APD) for the treatment of Paget's disease of bone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980344-9

Paget's disease of bone treated in five days with AHPrBP (APD) per Os

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980344-9

A single-day treatment of tumor-induced hypercalcemia by intravenous amino-hydroxypropylidene bisphosphonate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980344-9

Oral versus intravenous AHPrBP (APD) in the treatment of hypercalcemia of malignancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980344-9

Postabsorptive Urinary Hydroxyproline Test in Patients With Metastatic Bone Disease From Breast Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980344-9

Early morning hydroxyproline excretion in patients with breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980344-9

Modifications of a specific assay for hydroxyproline in urine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980344-9

Chlorothiazide-Induced Hypercalcemia in Juvenile Osteoporosis and Hyperparathyroidism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980344-9

Intravenous aminopropylidene bisphosphonate (APD) in the treatment of Paget's bone disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980344-9

Aminohexane diphosphonate in the treatment of Paget's disease of bone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980344-9

Treatment of Paget's disease of bone with intravenous 4-amino-1-hydroxybutylidene-1,1-bisphosphonate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980344-9

Efficacy of the bisphosphonate APD in the control of Paget's bone disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980344-9

Regulation of calcium absorption by 1,25,dihydroxy-vitamin D--studies of the effects of a bisphosphonate treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980344-9

Serum bone GLA-protein is not a sensitive marker of bone turnover in Paget's disease of bone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980344-9

Intravenous clodronate in the treatment and retreatment of Paget's disease of bone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980344-9

Quantitative bone scintigraphy in Paget's disease treated with APD

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980344-9

Radiological demonstration of healing in Paget's disease of bone treated with APD

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980344-9

Beneficial effects of aminohexane diphosphonate in patients with Paget's disease of bone resistant to sodium etidronate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980344-9

10.1016/S0002-9343(88)80344-9

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3261129%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

1 reference